|
| Reference | Subjects (sex, age, groups) | Platform manufacturer | Oscillation frequency/amplitude | Disability level of the subjects |
|
| Schuhfried et al., [29] | Two groups: intervention (1 male/5 female, 49.3 y) and placebo (2 male/4 female, 46.0 y) | Zeptor: Med system (Scisen GmbH, Germany) | From 1 Hz/3 mm until the patient does not tolerate a further increase. | Subjects with an impairment of ≤5 based on Kurtzke’s expanded disability status scale (EDSS). |
| Jackson et al., [30] | 15 subjects (3 male/12 female, 54.6 y) were divided in two groups. A group was submitted to 2 Hz and the other one was submitted to 26 Hz | Maxuvibe platform (Fitgroup BV, Hoogstraat, Holland) | 2 or 26 Hz/6 mm | Subjects with an impairment of ≤6.5 based on Kurtzke’s EDSS. |
| Schyns et al., [31] | Two groups: Group I (5 females/3 males, 45.8 years old) and Group II (7 females/1 male, 49.5 years old) | VibroGym International BV, The Netherlands | 40 Hz/2 mm | Subjects with an impairment between 1 and 6 on the Hauser ambulation index |
| Wunderer et al., [32] | 3 subjects | VibroGym apparatus (Professional model, ES Haarlem, The Netherlands) | 40 Hz/2 mm | Scores in the disease steps scale of the subjects were 2 with abnormal gait, no need for walking aid, 4 depend on unilateral support, and 5 need for bilateral support. |
| Broekmans et al., [28] | Two groups: WBV group (7 females/4 males, 46.1 years old) and Control group (11 females/3 male, 49.7 years old) | Alpha Vibe Nijverdal, The Netherlands | 25–45 Hz/2.5 mm | Subjects with an EDSS score ranging from 1.5 to 6.5 |
|
